Drugs are primal parts of the chain of medical treatment that often makeup a substantial chunk of the final cost of healthcare, after the cost of diagnosis.
In this part of the world where encompassing health insurance coverage isn’t available to all, drugs can either restrict or widen access t
```
Members Only
Login or create an account to continue
This article is available to registered BusinessDay readers. Please login if you already have an account, or create a new account to continue reading.
New to BusinessDay? Register now and start reading.
```
